Talwar Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth -33.11%
- Profit Growth -76.75%
- Ebitda -26.73%
- Net Worth 2.15%
- Total Assets -27.39%
About Talwar Drugs
Talwar Drugs Private Limited (TDPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 1995 and has a history of 29 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Talwar, Aman Talwar, and Renu Talwar serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1995PTC020602
- Company No.
020602
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1995
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Talwar Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Talwar  | Director | 29-Sep-2001 | Current |
| Aman Talwar | Whole-Time Director | 07-Sep-2012 | Current |
| Renu Talwar | Director | 31-Jul-2014 | Current |
Financial Performance of Talwar Drugs.
Talwar Drugs Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 33.11% decrease. The company also saw a substantial fall in profitability, with a 76.75% decrease in profit. The company's net worth moved up by a moderate rise of 2.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Talwar Drugs?
In 2019, Talwar Drugs had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Talwar Drugs?
Unlock and access historical data on people associated with Talwar Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Talwar Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Talwar Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
